Molecular Formula | C13H21ClN6O4 |
Molar Mass | 360.8 |
Density | 1.55g/cm3 |
Melting Point | 170-172°C |
Boling Point | 588.4°C at 760 mmHg |
Flash Point | 309.7°C |
Solubility | Soluble in Water: >20 mg/mL |
Vapor Presure | 7.95E-14mmHg at 25°C |
Appearance | White solid |
Color | white |
Maximum wavelength(λmax) | ['253nm(H2O)(lit.)'] |
Merck | 14,9899 |
Storage Condition | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
Stability | Hygroscopic |
Refractive Index | 1.673 |
MDL | MFCD01861507 |
Use | For anti-virus, anti-hepatitis, etc |
Risk Codes | R36/37/38 - Irritating to eyes, respiratory system and skin. R22 - Harmful if swallowed |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S24/25 - Avoid contact with skin and eyes. |
UN IDs | 3077 |
WGK Germany | 3 |
HS Code | 29335990 |
This product is L-valine -2-[(6-oxo-2-amino -1, 6-dihydro-9-phenanopurine -9-yl) methoxy] ethyl ester hydrochloride. The content of C13H20N604 • HCl shall not be less than 98.0% calculated as anhydrous.
take this product, precision weighing, add water to dissolve and quantitatively dilute to make a solution containing about 40mg per lml, and determine according to law (General rule 0621), the specific rotation was -8.5 ° to -11.5 °.
take 0.10g of this product, Add 10ml of water to dissolve, and measure according to law (General rule 0631). The pH value should be 4.0~6.0.
take the right amount of this product, precision weighing, plus O.Olmol/L potassium dihydrogen phosphate solution (adjusted to pH 3.0 with phosphoric acid) is dissolved and diluted to prepare a solution containing about 0.5mg per lml as a test solution, in a 0.01 measuring flask, dilute to the scale with the above 3.0 mol/L potassium dihydrogen phosphate solution (pH), shake well, and use it as a control solution; Take about 15mg of acyclovir reference substance, and weigh it precisely, in a 50ml measuring flask, add 0.1mol/L sodium hydroxide solution (2ml) was dissolved, then diluted with water to scale, and then shaken well as the reference stock solution of acyclovir, the mixture was diluted to the mark with the above 0.01mol/L potassium dihydrogen phosphate solution (pH 3.0) and shaken to obtain a control solution of acyclovir. According to the chromatographic conditions under the content determination item, the control solution, the acyclovir reference solution and the test solution are respectively accurately measured at 20 u1, and the human liquid chromatograph is respectively injected, the chromatogram was recorded to 6 times the peak retention time of valacyclovir. If there are impurity peaks in the chromatogram of the test solution, the content of acyclovir shall not exceed 1.5% calculated by the peak area according to the external standard method; The sum of other impurity peak areas shall not be greater than the main peak area of the control solution (0.5%).
take an appropriate amount of this product, accurately weigh, add water to dissolve and quantitatively dilute to make a solution containing about 50mg per lml, as a test solution; Separately take acetone, Tetrahydrofuran, the appropriate amount of methanol and ethanol is precisely weighed and diluted with water to prepare a solution containing about 250ug of acetone, 8ug of tetrahydrofuran, 150ug of methanol and 250ug of ethanol per 1 ml, which is used as a reference solution. 5ml of each of the test solution and the reference solution were accurately measured, respectively placed in the headspace bottle and sealed. According to the determination method of residual solvent (General 0861 second method), a capillary column with 5% phenyl 95% dimethyl polysiloxane as stationary liquid was used; The initial temperature was 40 C, and the temperature was maintained for 7 minutes, the temperature was raised to 120°C at a rate of 8°C per minute for 5 minutes; The detector temperature was 250°C; The gasification chamber temperature was 200°C; The headspace bottle equilibrium temperature was 85°C for 30 minutes. Take the reference solution into the headspace, the separation degree between the peaks of each component shall meet the requirements. Then the sample solution and the reference solution were injected with headspace, and the chromatogram was recorded. According to the external standard method, the residual amount of acetone, Tetrahydrofuran, methanol and ethanol shall be calculated by the peak area.
take an appropriate amount of this product, accurately weigh it, add water to dissolve and quantitatively dilute it to make a solution containing about 250mg per lml as a test solution; Take an appropriate amount of N, N-dimethylformamide, precision weighing, adding water to dissolve and quantitatively dilute to prepare a solution containing about 220ug of N, N-dimethylformamide per 1 ml as a reference solution. According to the determination method of residual solvent (General 0 861 third method), a capillary column with 5% phenyl 95% dimethyl polysiloxane as stationary liquid was used; The initial temperature was 60 C, and the time was maintained for 7 minutes, the temperature was raised to 120°C at a rate of 8°C per minute for 5 minutes; The detector temperature was 250°C; And the inlet temperature was 200°C. The lul of the test solution and the reference solution are accurately measured, respectively injected into the human gas chromatograph, the chromatogram is recorded, and the peak area is calculated according to the external standard method. The residual amount of N ,N-dimethylformamide should comply with the regulations.
take this product, according to the moisture determination method (General 0832 first method 1), containing water not more than 8.0%.
take l.Og of this product and check it according to law (General rule 0841). The residue left shall not exceed 0.1%.
The residue left under the item of burning and flooding shall not contain more than 20 parts per million of heavy metals for examination by law (General rule 0821, Law II).
measured by high performance liquid chromatography (General 0512).
silica gel bonded with eighteen alkyl silane as a filler; 0.Olmol/L potassium dihydrogen phosphate solution (adjusted to pH 3.0 with phosphoric acid)-methanol (85:15) as mobile phase; The detection wavelength was 251nm; The column temperature was 35°C. The acyclovir control solution (1 ml) and the Valacyclovir hydrochloride control solution (5ml) were mixed with each other and used as the applicable solution for the system, the resolution of valaciclovir peak and acyclovir peak should meet the requirements.
take this product about 50mg, precision weighing, 100ml flask, plus O.Olmol /L potassium dihydrogen phosphate solution (pH 3.0) was dissolved and diluted to the scale, then shaken; The appropriate amount was accurately measured and diluted with mobile phase to prepare a solution containing about 50ug per 1 ml, as a test solution, 20ul was injected into the liquid chromatograph with precision, and the chromatogram was recorded. Another valaciclovir hydrochloride reference substance was determined by the same method. According to the external standard method to calculate the peak area, that is.
antiviral drugs.
sealed and stored in a dry place.
This product contains valaciclovir hydrochloride (C13H20N604 • HCI) should be 90.0% ~ 110.0% of the label amount.
This product is a film-coated tablet, white or off-white after removal of the coating.
In the chromatogram recorded under the content determination item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the control solution.
Take 10 tablets of this product, precision weighing, fine grinding, precision weighing appropriate amount (about 50mg equivalent to valacyclovir hydrochloride), put it in a 100ml measuring flask, add O.Olmol/L potassium dihydrogen phosphate solution (adjusted to pH 3.0 with phosphoric acid) was dissolved and diluted to the scale, and then it was shaken, left standing, filtered, and then the appropriate amount of filtrate was taken, diluted with mobile phase to a solution containing about 50% per 1 ml, as a test solution, measured and calculated according to the method under valacyclovir hydrochloride.
with valaciclovir hydrochloride.
(1)0.15g (2)0.3g (3)0.5g
sealed and stored in a dry place.
This product contains valaciclovir hydrochloride (C13H20N604 • HCl) should be 90.0% ~ 110.0% of the label amount.
The content of this product is white or white powder.
In the chromatogram recorded under the content determination item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the control solution.
take the contents under the item of difference in loading amount, mix them evenly, weigh an appropriate amount (about 50mg of valacyclovir hydrochloride) precisely, put it in a 100ml measuring flask, and add O.Olmol/L potassium dihydrogen phosphate solution (adjusted to pH 3.0 with phosphoric acid) was dissolved and diluted to the scale, and then it was shaken, left standing, filtered, and then the appropriate amount of filtrate was taken, diluted with mobile phase to a solution containing about 50ug per 1 ml, as a test solution, measured and calculated according to the method under the item valacyclovir hydrochloride.
with valaciclovir hydrochloride.
0.15g
sealed and stored in a dry place.